Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-24 · accession 0001855763-22-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | 2022-05-24 | LEXX | REESE ALBERT L JR | Dir | A - Grant | $1.96 | +5,000 | 10.9K | +85% | +$9,800 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2022-05-24 | A | A | 5,000 | $1.96 | 10,917 | D | — | — |